RU2013145154A - Анализ экспрессии биомаркеров в клетках с помощью кластеров - Google Patents

Анализ экспрессии биомаркеров в клетках с помощью кластеров Download PDF

Info

Publication number
RU2013145154A
RU2013145154A RU2013145154/15A RU2013145154A RU2013145154A RU 2013145154 A RU2013145154 A RU 2013145154A RU 2013145154/15 A RU2013145154/15 A RU 2013145154/15A RU 2013145154 A RU2013145154 A RU 2013145154A RU 2013145154 A RU2013145154 A RU 2013145154A
Authority
RU
Russia
Prior art keywords
cell
cells
clusters
intensity
expression
Prior art date
Application number
RU2013145154/15A
Other languages
English (en)
Russian (ru)
Inventor
Колин Крэйг МАККАЛЛОК
Фиона ДЖИНТИ
Кристофер Джеймс СЕВИНСКИ
Original Assignee
Дженерал Электрик Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дженерал Электрик Компани filed Critical Дженерал Электрик Компани
Publication of RU2013145154A publication Critical patent/RU2013145154A/ru

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F18/00—Pattern recognition
    • G06F18/20—Analysing
    • G06F18/21—Design or setup of recognition systems or techniques; Extraction of features in feature space; Blind source separation
    • G06F18/211—Selection of the most significant subset of features
    • G06F18/2115—Selection of the most significant subset of features by evaluating different subsets according to an optimisation criterion, e.g. class separability, forward selection or backward elimination
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
    • G06V10/00—Arrangements for image or video recognition or understanding
    • G06V10/70—Arrangements for image or video recognition or understanding using pattern recognition or machine learning
    • G06V10/77—Processing image or video features in feature spaces; using data integration or data reduction, e.g. principal component analysis [PCA] or independent component analysis [ICA] or self-organising maps [SOM]; Blind source separation
    • G06V10/771—Feature selection, e.g. selecting representative features from a multi-dimensional feature space
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
    • G06V20/00—Scenes; Scene-specific elements
    • G06V20/60—Type of objects
    • G06V20/69—Microscopic objects, e.g. biological cells or cellular parts
    • G06V20/698—Matching; Classification
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Theoretical Computer Science (AREA)
  • Immunology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Evolutionary Computation (AREA)
  • Data Mining & Analysis (AREA)
  • Artificial Intelligence (AREA)
  • Multimedia (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Software Systems (AREA)
  • General Engineering & Computer Science (AREA)
  • Databases & Information Systems (AREA)
  • Hospice & Palliative Care (AREA)
  • Computing Systems (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Image Processing (AREA)
RU2013145154/15A 2011-04-22 2012-04-23 Анализ экспрессии биомаркеров в клетках с помощью кластеров RU2013145154A (ru)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201161478224P 2011-04-22 2011-04-22
US61/478,224 2011-04-22
US13/252,080 2011-10-03
US13/252,072 US20120269418A1 (en) 2011-04-22 2011-10-03 Analyzing the expression of biomarkers in cells with clusters
US13/252,072 2011-10-03
US13/252,080 US20120271553A1 (en) 2011-04-22 2011-10-03 Analyzing the expression of biomarkers in cells with clusters
PCT/EP2012/057394 WO2012143561A2 (en) 2011-04-22 2012-04-23 Analyzing the expression of biomarkers in cells with clusters

Publications (1)

Publication Number Publication Date
RU2013145154A true RU2013145154A (ru) 2015-05-27

Family

ID=47021377

Family Applications (3)

Application Number Title Priority Date Filing Date
RU2013145151/15A RU2013145151A (ru) 2011-04-22 2012-04-23 Анализ экспрессии биомаркеров в клетках с помощью моментов распределения
RU2013145162/15A RU2013145162A (ru) 2011-04-22 2012-04-23 Анализ экспрессии биомаркеров в клетках с помощью кластеров
RU2013145154/15A RU2013145154A (ru) 2011-04-22 2012-04-23 Анализ экспрессии биомаркеров в клетках с помощью кластеров

Family Applications Before (2)

Application Number Title Priority Date Filing Date
RU2013145151/15A RU2013145151A (ru) 2011-04-22 2012-04-23 Анализ экспрессии биомаркеров в клетках с помощью моментов распределения
RU2013145162/15A RU2013145162A (ru) 2011-04-22 2012-04-23 Анализ экспрессии биомаркеров в клетках с помощью кластеров

Country Status (8)

Country Link
US (5) US20120270752A1 (enExample)
EP (4) EP2700042B1 (enExample)
JP (4) JP6063446B2 (enExample)
BR (4) BR112013027122A2 (enExample)
CA (4) CA2833497A1 (enExample)
RU (3) RU2013145151A (enExample)
SG (4) SG194588A1 (enExample)
WO (4) WO2012143558A2 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201111594D0 (en) * 2011-07-06 2011-08-24 Equateq Ltd New improved process
KR20150094618A (ko) * 2012-12-06 2015-08-19 클래리언트 다이아그노스틱 서비시즈, 인크. 생물학적 시편의 분할 스크린 디스플레이와 그 레코드를 포착하기 위한 시스템 및 방법
US9488639B2 (en) * 2013-02-25 2016-11-08 Flagship Biosciences, Inc. Cell-based tissue analysis
US8995740B2 (en) 2013-04-17 2015-03-31 General Electric Company System and method for multiplexed biomarker quantitation using single cell segmentation on sequentially stained tissue
JP2016523550A (ja) * 2013-07-03 2016-08-12 コイン アイピー ホールディングス、 エルエルシー 化学的または生物学的物質に対する応答の予測方法
US9322051B2 (en) 2013-10-07 2016-04-26 General Electric Company Probing of biological samples
US9298968B1 (en) * 2014-09-12 2016-03-29 Flagship Biosciences, Inc. Digital image analysis of inflammatory cells and mediators of inflammation
JP6791598B2 (ja) * 2015-01-22 2020-11-25 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 異なる細胞サブセットの比率の決定方法およびシステム
US9953133B2 (en) 2015-06-03 2018-04-24 General Electric Company Biological data annotation and visualization
US10672505B2 (en) 2015-06-03 2020-06-02 General Electric Company Biological data annotation and visualization
WO2017109860A1 (ja) * 2015-12-22 2017-06-29 株式会社ニコン 画像処理装置
US20180032681A1 (en) * 2016-07-29 2018-02-01 General Electric Company Biological feature analysis technique
US11436719B2 (en) 2017-02-16 2022-09-06 Kyoto University Cell evaluation method, cell evaluation device, and recording medium storing cell evaluation program
US10242473B2 (en) * 2017-03-22 2019-03-26 Sas Institute Inc. Computer system to generate scalable plots using clustering
CA3058195A1 (en) 2017-04-28 2018-11-01 4D Path Inc. Apparatus, systems, and methods for rapid cancer detection
KR101990430B1 (ko) * 2017-06-22 2019-06-18 한국과학기술원 암의 재발 예후 예측을 위한 바이오마커 발굴 시스템 및 방법
AU2018304381A1 (en) 2017-07-21 2020-02-06 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods for analyzing mixed cell populations
US10706328B2 (en) * 2018-05-07 2020-07-07 Google Llc Focus-weighted, machine learning disease classifier error prediction for microscope slide images
US10971255B2 (en) * 2018-09-14 2021-04-06 Zasti Inc. Multimodal learning framework for analysis of clinical trials
US11101043B2 (en) 2018-09-24 2021-08-24 Zasti Inc. Hybrid analysis framework for prediction of outcomes in clinical trials
EP3886696A4 (en) * 2018-11-29 2022-08-24 SomaLogic Operating Co., Inc. Methods for determining disease risk combining downsampling of class-imbalanced sets with survival analysis
US11128667B2 (en) * 2018-11-29 2021-09-21 Rapid7, Inc. Cluster detection and elimination in security environments
CN113158982A (zh) * 2021-05-17 2021-07-23 广东中卡云计算有限公司 一种半介入式的目标关键点标注方法
WO2023033056A1 (ja) * 2021-09-01 2023-03-09 イミュニティリサーチ株式会社 細胞集団同定システム、方法、およびプログラム
IT202200001817A1 (it) 2022-02-02 2023-08-02 Aizoon S R L Procedimento per la prognosi di una malattia in seguito ad un trattamento terapeutico, relativo sistema e prodotto informatico
IT202200005861A1 (it) 2022-03-24 2023-09-24 Aizoon S R L Procedimento per stimare una variabile di interesse associata ad una data malattia in funzione di una pluralità di diversi dati omici, relativo dispositivo e prodotto informatico
CA3207405A1 (en) 2022-07-25 2024-01-25 Aizoon S.r.l. Method for providing a clinical decision support, corresponding system for providing a clinical decision support, and computer program product

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6463438B1 (en) * 1994-06-03 2002-10-08 Urocor, Inc. Neural network for cell image analysis for identification of abnormal cells
US5740269A (en) * 1994-09-20 1998-04-14 Neopath, Inc. Method and apparatus for robust biological specimen classification
US6996549B2 (en) * 1998-05-01 2006-02-07 Health Discovery Corporation Computer-aided image analysis
US6282305B1 (en) * 1998-06-05 2001-08-28 Arch Development Corporation Method and system for the computerized assessment of breast cancer risk
US6337472B1 (en) * 1998-10-19 2002-01-08 The University Of Texas System Board Of Regents Light imaging microscope having spatially resolved images
JP2005503760A (ja) * 2001-01-24 2005-02-10 プロテイン デザイン ラブス， インコーポレイテッド 乳癌の診断方法、組成物および乳癌のモジュレーターのスクリーニング方法
WO2004013658A2 (en) * 2002-07-30 2004-02-12 Deutsches Krebsforschungszentrum Method and apparatus for multiple labeling detection and evaluation of a plurality of particles
US20040121413A1 (en) * 2002-12-20 2004-06-24 Aebersold Rudolf H. Androgen-regulated genes and uses for diagnosis, prognosis and treatment of prostate neoplastic conditions
US20050265588A1 (en) * 2004-02-03 2005-12-01 Bioimagene, Inc. Method and system for digital image based flourescent in situ hybridization (FISH) analysis
WO2006113747A2 (en) * 2005-04-19 2006-10-26 Prediction Sciences Llc Diagnostic markers of breast cancer treatment and progression and methods of use thereof
US8041090B2 (en) * 2005-09-10 2011-10-18 Ge Healthcare Uk Limited Method of, and apparatus and computer software for, performing image processing
US7933435B2 (en) * 2005-11-21 2011-04-26 Vala Sciences, Inc. System, method, and kit for processing a magnified image of biological material to identify components of a biological object
CN101484806A (zh) * 2006-05-17 2009-07-15 协乐民公司 一种对组织进行自动分析的方法
US7741045B2 (en) * 2006-11-16 2010-06-22 General Electric Company Sequential analysis of biological samples
US8019134B2 (en) * 2006-11-16 2011-09-13 Definiens Ag Automatic image analysis and quantification for fluorescence in situ hybridization
CA2678919A1 (en) * 2007-03-27 2008-10-02 Ranit Aharonov Gene expression signature for classification of cancers
WO2008137912A1 (en) * 2007-05-07 2008-11-13 Ge Healthcare Bio-Sciences Corp. System and method for the automated analysis of cellular assays and tissues
DK2156370T3 (da) * 2007-05-14 2012-01-23 Historx Inc Kompartmentadskillelse ved pixelkarakterisering under anvendelse af billeddata-clustering
EP2195467B1 (en) * 2007-09-06 2016-12-14 bioTheranostics, Inc. Tumor grading and cancer prognosis in breast cancer
EP2332087B1 (en) * 2008-07-25 2020-04-22 Fundação D. Anna Sommer Champalimaud E Dr. Carlos Montez Champalimaud Systems and methods of treating, diagnosing and predicting the occurrence of a medical condition
US9779213B2 (en) * 2008-07-25 2017-10-03 Fundacao D. Anna Sommer Champalimaud E Dr. Carlos Montez Champalimaud System for evaluating a pathological stage of prostate cancer
US20110091081A1 (en) * 2009-10-16 2011-04-21 General Electric Company Method and system for analyzing the expression of biomarkers in cells in situ in their tissue of origin
US8320655B2 (en) 2009-10-16 2012-11-27 General Electric Company Process and system for analyzing the expression of biomarkers in cells
WO2011087778A1 (en) * 2009-12-22 2011-07-21 The Children's Hospital Of Philadelphia Automated quantitative multidimensional volumetric analysis and visualization

Also Published As

Publication number Publication date
WO2012143556A3 (en) 2013-05-30
WO2012143562A2 (en) 2012-10-26
CA2833295A1 (en) 2012-10-26
US20120270752A1 (en) 2012-10-25
JP2014516413A (ja) 2014-07-10
JP6143743B2 (ja) 2017-06-07
WO2012143558A2 (en) 2012-10-26
US20140185905A1 (en) 2014-07-03
CA2833497A1 (en) 2012-10-26
EP2700042A2 (en) 2014-02-26
RU2013145162A (ru) 2015-05-27
WO2012143558A3 (en) 2012-12-20
JP2014521925A (ja) 2014-08-28
EP2700042B1 (en) 2021-03-17
WO2012143556A2 (en) 2012-10-26
EP2700037A2 (en) 2014-02-26
JP2014517954A (ja) 2014-07-24
BR112013027124A2 (pt) 2017-01-10
BR112013027125A2 (pt) 2017-01-10
JP6163152B2 (ja) 2017-07-12
WO2012143561A2 (en) 2012-10-26
BR112013027123A2 (pt) 2017-01-10
EP2700036A2 (en) 2014-02-26
BR112013027122A2 (pt) 2017-01-10
EP2700038A2 (en) 2014-02-26
US20120269418A1 (en) 2012-10-25
US20120269419A1 (en) 2012-10-25
WO2012143561A3 (en) 2013-05-23
CA2833428A1 (en) 2012-10-26
SG194594A1 (en) 2013-12-30
US20120271553A1 (en) 2012-10-25
WO2012143562A3 (en) 2013-02-28
SG194592A1 (en) 2013-12-30
SG194590A1 (en) 2013-12-30
JP2014521926A (ja) 2014-08-28
EP2700038B1 (en) 2021-04-21
SG194588A1 (en) 2013-12-30
CA2833804A1 (en) 2012-10-26
JP6063446B2 (ja) 2017-01-18
RU2013145151A (ru) 2015-05-27
JP6063447B2 (ja) 2017-01-18

Similar Documents

Publication Publication Date Title
RU2013145154A (ru) Анализ экспрессии биомаркеров в клетках с помощью кластеров
JP2014517954A5 (enExample)
US11257209B2 (en) Cancer risk stratification based on histopathological tissue slide analysis
JP2014516413A5 (enExample)
CN112912923B (zh) 基于距离的组织状态确定
JP7563764B2 (ja) 癌関連ｔｃｒレパートリの抗原非依存的デノボ予測のコンピュータシステム及び方法
Zhang et al. ANPELA: significantly enhanced quantification tool for cytometry‐based single‐cell proteomics
KR102044094B1 (ko) 딥 러닝 기반 유전체 발현량 해석을 통한 암 또는 정상 판별 방법 및 그 장치
TW202119430A (zh) 癌症風險檢測、評估與預測系統
Kheterpal et al. Role of imaging in low-grade cutaneous B-cell lymphoma presenting in the skin
WO2021229079A1 (en) Single-cell morphology analysis for disease profiling and drug discovery
Colbaugh et al. Ensemble transfer learning for Alzheimer's disease diagnosis
Landry et al. Establishing the utility of multi-platform liquid biopsy by integrating the CSF methylome and proteome in CNS tumours
Wu et al. An examination of TNM staging of melanoma by a machine learning algorithm
Fanizzi et al. Transfer learning approach in pre-treatment CT images to predict therapeutic response in advanced malignant pleural mesothelioma
JP2021521812A (ja) 免疫療法反応の改善予測バイオマーカーとしての腫瘍機能変異及びエピトープ負荷
KR102875963B1 (ko) 면역 체크 포인트 저해제의 약리 작용의 평가 방법, 산출 방법, 평가 장치, 산출 장치, 평가 프로그램, 산출 프로그램, 기록 매체, 평가 시스템 및 단말 장치
KR102477319B1 (ko) 암 모니터링의 방법, 산출 방법, 평가 장치, 산출 장치, 평가 프로그램, 산출 프로그램, 평가 시스템, 및 단말 장치
RU2013145829A (ru) Анализ экспрессии биомаркеров в клетках с помощью моментов распределения
CN116052889B (zh) 一种基于血液常规指标检测的sFLC预测系统
Xiong et al. Analysis of cytokine release assay data using machine learning approaches
Karz et al. MetFinder: a neural network-based tool for automated quantitation of metastatic burden in histological sections from animal models
Jung Statistics in experimental design, preprocessing, and analysis of proteomics data
Zhang et al. Biomarkers in Immunology: from Concepts to Applications
CN120998487A (zh) 结合病理图像与临床变量的肺癌患者预后评估方法及系统

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20161110